|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00673 CHINA HEALTH
Nominal 
0.690 0.000 (0.000%) | 2025/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/09 HKD(K$) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | |
| Turnover | 19,610 | 4.979% | 18,680 | 28,268 | 32,324 | 42,022 |
| Cost of Sales | (17,763) | 6.448% | (16,687) | (23,233) | (23,049) | (32,304) |
| Gross Profit | 1,847 | -7.326% | 1,993 | 5,035 | 9,275 | 9,718 |
| 2025/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/09 HKD(K$) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | (864) | (17,201) | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | (1) | 0 | |
| Profit / (Loss) before Taxation | (10,889) | -38.155% | (17,607) | (16,485) | (27,497) | (4,702) | |
| Taxation | 50 | -- | (17) | (56) | (25) | (82) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 476 | 100.844% | 237 | 1,481 | (89) | (423) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (10,363) | -40.398% | (17,387) | (15,060) | (27,611) | (5,207) | |
| 2025/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/09 HKD(K$) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | |
| Net Finance Costs / (Income) | 532 | -- | (451) | (99) | 795 | 162 |
| Depreciation & Amortisation | 708 | -25.000% | 944 | 1,740 | 2,599 | 2,504 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/09 - Interim | %Chg (Compare to Interim) | 2024/09 | 2023/09 | 2022/09 | 2021/09 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/09 - Interim | %Chg (Compare to Interim) | 2024/09 | 2023/09 | 2022/09 | 2021/09 | |
| EPS (cts) | -2.110 | -26.609% | -2.875 | -2.555 | -5.294 | -1.009 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | (0.036) | -- | 0.072 | 0.125883 | 0.104848 | 0.158998 |
| Remarks: | Real time quote last updated: 16/12/2025 09:52 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -10,363 |
| %Change | -40.398% |
| EPS / (LPS) | HKD -0.021 |
| NBV Per Share ($) | HKD -0.036 |